Lupin Quarterly Results for Trading Insights

LUPIN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,485 Cr
QSept 2025
Quarterly Results

Lupin Quarterly Results Key Highlights

  • Revenue of ₹6,921 Cr in Sept 2025 (+23.2% vs Mar 2025, +25.0% vs Sept 2024)
  • Net Profit of ₹1,485 Cr in Sept 2025 (+89.9% vs Mar 2025, +72.7% vs Sept 2024)
  • EBITDA of ₹2,215 Cr in Sept 2025 (+74.0% vs Mar 2025)
  • Operating Margin of 31.0% in Sept 2025 (+9.0pp vs Mar 2025)
  • Earnings Per Share of ₹32.36 in Sept 2025 (+91.1% vs Mar 2025)

Lupin Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 6,921 5,619 6,243 5,539 4,924 23.2% 25.0%
Net Profit (₹ Cr) 1,485 782 1,222 860 368 - -
EBITDA (₹ Cr) 2,215 1,273 1,702 1,207 960 - -
EPS (₹) 32.36 16.93 26.70 18.70 7.89 - -
Operating Margin (%) 31.0% 22.0% 26.0% 21.0% 19.0% - -

Lupin Share Price Trend Around Quarterly Results

Visualize Lupin's 1-year price movement across quarterly results — ideal for logging trades in Lupin share price chart using Tickjournal. All values in ₹.

Related Pages for Lupin

Additional stock information and data for LUPIN

LUPIN shareholder distribution
LUPIN 52-week performance
LUPIN price book multiple
LUPIN earnings multiple
LUPIN fair value
Lupin financial data
LUPIN value investing

Profitability Ratios

Profit Margin 21.5%
EBITDA Margin 32.0%
Operating Margin 31.0%
ROE (Annual) 34.3%

Balance Sheet Highlights

Total Assets ₹29,205 Cr
Total Equity ₹17,294 Cr
Current Assets ₹16,799 Cr
Current Liabilities ₹2,949 Cr

Cash Flow Analysis

Operating Cash Flow ₹3,000 Cr
Investing Cash Flow ₹-4,172 Cr
Financing Cash Flow ₹1,732 Cr
Net Cash Flow ₹560 Cr

Current Market Data

Current Price ₹2214.30
Exchange NSE
Last Updated Jan 07, 2026

Revenue Trend (₹ Cr)

Sept 2024 5,539
Jun 2025 6,243
Mar 2025 5,619
Sept 2025 6,921

Net Profit Trend (₹ Cr)

Sept 2024 860
Jun 2025 1,222
Mar 2025 782
Sept 2025 1,485

Operating Margin Trend (%)

Sept 2024 21.0%
Jun 2025 26.0%
Mar 2025 22.0%
Sept 2025 31.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Lupin quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1782.6 14,875 3,125 +10.8% - 21.0% 137.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 4092.2 3,219 591 +11.3% - 18.4% 233.3
Cipla
Sept 2025 		₹121,238.47 Cr 1467.9 7,716 1,353 +12.0% - 17.5% 87.7
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1242.8 9,135 1,337 +1.1% - 14.6% 76.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores